AMI Cardiogenic Shock

Patient Identification

Early Identification of Cardiogenic Shock Improves Outcomes

Timely treatment adhering to a best practice protocol, that includes early use of mechanical circulatory support, hemodynamic monitoring, and aggressive reduction of inotropes and pressors, can help patients achieve myocardial recovery.1

 

Implementing a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Benham Tehrani, MD, discuss implementing a cardiogenic shock protocol.

 

Achieving >70% AMI Cardiogenic Shock Survival: Insight from National Cardiogenic Shock Initiative (NCSI) Study

William O'Neill, MD, explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPi) are used to drive care for patients after angioplasty.

Explore the Education Library

 

Interview with Dr. Pappalardo on “Optimal ICU Management of Patients Requiring Hemodynamic Support with an Impella® Device"

Watch the interview with Dr. Pappalardo and learn more about ICU Management to patients requiring hemodynamic support.

 

Digital Summit Recording 2021

Explore our Digital Summit 2021 Recordings

Discover all Posts from the Education Library

Discover all Posts from the Education Library

Learn more about our Education Library here.

Clinical Evidence

Learn more about key findings from NCSI Study and other ongoing clinical trials.

References

  1. O'Neill, W.W., TCT 2020.

NPS-2631

This information is intended for use by customers, patients, and healthcare professionals in Europe only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside Europe, and the information from other sites you visit may not be appropriate for use in Europe.